Global health and equity in access to genomics and clinical trials with novel therapies

Bibliographic Details
Main Author: Amit Oza
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X18300950
id doaj-6199bec46e034e2a889e82ceea6aeb4a
record_format Article
spelling doaj-6199bec46e034e2a889e82ceea6aeb4a2020-11-25T02:02:57ZengElsevierThe Lancet Global Health2214-109X2018-03-016S25Global health and equity in access to genomics and clinical trials with novel therapiesAmit Oza0Princess Margaret Cancer Centre, Toronto, ON, Canadahttp://www.sciencedirect.com/science/article/pii/S2214109X18300950
collection DOAJ
language English
format Article
sources DOAJ
author Amit Oza
spellingShingle Amit Oza
Global health and equity in access to genomics and clinical trials with novel therapies
The Lancet Global Health
author_facet Amit Oza
author_sort Amit Oza
title Global health and equity in access to genomics and clinical trials with novel therapies
title_short Global health and equity in access to genomics and clinical trials with novel therapies
title_full Global health and equity in access to genomics and clinical trials with novel therapies
title_fullStr Global health and equity in access to genomics and clinical trials with novel therapies
title_full_unstemmed Global health and equity in access to genomics and clinical trials with novel therapies
title_sort global health and equity in access to genomics and clinical trials with novel therapies
publisher Elsevier
series The Lancet Global Health
issn 2214-109X
publishDate 2018-03-01
url http://www.sciencedirect.com/science/article/pii/S2214109X18300950
work_keys_str_mv AT amitoza globalhealthandequityinaccesstogenomicsandclinicaltrialswithnoveltherapies
_version_ 1724950427937538048